Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Phase IV, Follow-up Study to Evaluate the 17-year Immune Persistence of a Single Dose of Inactivated or Alive Attenuated Hepatitis A Vaccine in Healthy Chinese Participants in the Parent Trial(PRO-HA-4013 )

NCT07855705 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.

NCT NCT07855705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07855705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Phase IV, Follow-up Study to Evaluate the 17-year Immune Persistence of a Single Dose of Inactivated or Alive Attenuated Hepatitis A Vaccine in Healthy Chinese Participants in the Parent Trial(PRO-HA-4013 )
Lead sponsor
Sinovac Biotech Co., Ltd
Phase
Observational
Overall status
Completed
Start date
January 13, 2026
Completion date
March 9, 2026
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis a